chrisvoncsefalvay/vaers-outcomes huggingface dataset:
noticed a  red streak (between elbow and wrist); 5 tiny nonpainful blisters; Lips chapped and peeled; This is a spontaneous report from a contactable consumer (reporting for herself) via Medical information team. A 74-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: unknown), via an unspecified route of administration on an unspecified date (at the age of 74-years) as SINGLE DOSE in Arm Left for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, days after she received the first shot of vaccination on the left arm, she noticed a red streak (between elbow and wrist) with 5 tiny nonpainful blisters. Also reported her Lips chapped and peeled after both shots of vaccination. She was advised to take Benadryl after the shot however she didn't take the Benadryl. Outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
I had flu-like symptoms after receiving my 2nd dose of the Moderna vaccine.  I had chills, fever (99-101), body aches, and fatigue.  These began the night I received the vaccine and lasted for 2-3 days afterward.  My arm was also really sore, bruised, red, and hot.  The redness on my arm continued to spread down toward my elbow for 2-4 days before beginning to fade away.
Information has been received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 20-AUG-2018, patient was administered with VARIVAX (lot number M036272, that expired on 17-AUG-2018; strength, dose, route were not reported) for prophylaxis. No adverse effects reported.
Rash on posterior thigh, moderate severity, raised welts, started one week post-vaccination.  Still occurring over a week later. No improvement with hydrocortisone cream.
Patient had eyes closed and was not responsive 10 minutes after getting vaccine,. Pharmacist checked breathing and pulse which were ok. 911 was called to check out the patient. She did not go to the hospital.
Pt has COPD and is on 3L NC with former tobacco dependence.  She has had increased shortness of breath with activity, fatigue, generalized weakness, and loss of appetite.
At 11pm I had an immediate onset fever and chills. Took Tylenol and it went away pretty quickly. Woke up at about 2am with a fever again, took Tylenol. Trouble sleeping the rest of the night with hot flashes. Migraine at about 7am, took migraine medicine, went away around 10am. Since then, major body aches and feeling out of it. Feeling better April 5th with only arm soreness.
Patient had pap smear 8/2023 that showed HPV positive. It is unknown what strain of HPV from the pap; This spontaneous report was received from other health professional referring to a 30 year old non pregnant female patient.      The patient's pertinent current conditions, medical history, previous drug reactions or allergies, and concomitant medications were not reported.  On an unknown date in 2009, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL)  intramuscular injection, administered intramuscularly (IM) as prophylaxis (strength, dose, frequency, lot # and expiration date were not provided). On an unknown date in 2010, she was vaccinated with the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL)  intramuscular injection, IM as prophylaxis (strength, dose, frequency, lot # and expiration date were not provided).    On an unspecified date in August 2023, a Papanicolaou test (also reported as pap smear) was performed and showed Human Papillomavirus (HPV) positive, it was unknown what was the strain of HPV; thus, on that date, she experienced human papilloma virus test positive. No treatment was giving regarding the event. At the time of this report, she had not recovered from the event.   The causal relationship between human papilloma virus test positive and quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) was not provided.
don't have my second dose and all ready past 2 month; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (don't have my second dose and all ready past 2 month) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (don't have my second dose and all ready past 2 month). At the time of the report, PRODUCT DOSE OMISSION ISSUE (don't have my second dose and all ready past 2 month) had resolved.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Injection site soreness, bodyaches later day of injection. Fever up to 104, 09/24 and 102.5 09/25. Bodyaches, headache. Erythema measures 11 cm x 8 cm around injection site.
chills; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and VOMITING (vomiting) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and VOMITING (vomiting). At the time of the report, CHILLS (chills) and VOMITING (vomiting) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient with a history of WPW S/P ablation. Developed chest pain and shortness of breath approximately 30 minutes after vaccination that persisted into the next day. Was evaluated in ED and had cardiac evaluation that was negative.
MD reports some of pt devel a lump @ inj site p/vax;this lump may persist for up to one month;
Pt c/o headaches x 5 days. 9/10/07 pt /co H/A with vomiting. Pt sent to ER for CT scan. Pt received Meningitis vaccine; 8/01/07 (Menactra). 10/25/07-records received from facility for DOS 9/11-9/15/07-DC DX: Viral meningitis. Herpes Zoster. presented with 5 day history of headache, photophobia, vomiting and new rash on his right flank. Dermatomal rash. Vesicular lesions. Developed throbbing frontal headache, presumed concussion after playing lacrosse. Increased fatigue and decreased appetite.
Per MOC, fever started ~30 minutes after the immunization. The area around the injection site turned bright red and hives developed on his leg. MOC gave him BENADRYL, and the hives began to go away in ~24 hours.
throat swelling; numbness in knees and feet; numbness in knees and feet; This is a spontaneous report from a contactable consumer (patient mother). A 15-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) at 15-years-old, dose 1 via an unspecified route of administration, administered in Arm Left on 15May2021 11:38 (Batch/Lot Number: EW0173) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included asthma. Vaccination Facility Type: Pharmacy. No history of previous immunization with the Pfizer vaccine considered as suspect. No additional Vaccines Administered on Same Date of the Pfizer Suspect. Additional Information for Other Conditions: consumer stated that patient had probably mostly grown out of it. Patient was diagnosed whenever he was three years old. The patient's concomitant medications were not reported. The patient received first dose of vaccine and experienced throat swelling (his throat closed up a little bit), numbness in knees and feet about 12 minutes after vaccine on 15May2021 11:50 with outcome of recovered in 15May2021. Therapeutic measures were taken as a result of throat swelling, it recovered completely after patient took Benadryl. No investigation assessment. The events did not require a visit to: Emergency Room or Physician Office. They gave patient Benadryl there, and told reporter if patient has anymore issues to take him to the emergency room. No prior Vaccinations within 4 weeks. the consumer wanted to see if patient should get the second dose of the covid vaccine, was also going to check with patient's doctor.
Tingling in feet, lower legs began same day several hours after vaccine injected. The tingling is mild, but ongoing, and has continued in the fours months since receiving the first dose of the vaccine. It does not interfere with my everyday activities, but is concerning that it didn't subside within a few days or a week after vaccination. I was advised not to receive the second dose of Pfizer.
3/13/23 and the next day, I woke up with coughing with phlegm and I felt like somebody hit me with a truck. I stayed in bed and asleep. The second day, I had a wellness check with my doctor. I called them to cancel this. They prescribed zinc, magnesium and PAXLOVID. I took it that night as my first dose and was better the next day. I felt like I had a fever. I could not get up. My mother had COVID-19 prior to 3/13/23. I was still tired until last week as far as energy levels.
Started feeling poorly the night of vaccination. Next day area of sight turned red, edema, warm, painful. Went to ER, gave her Keflex.
Severe pain at the injection site; fever; flu like symptoms; This case was reported by a consumer and described the occurrence of injection site pain in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included breast cancer (2 times breast cancer survivor).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain, fever and influenza-like symptoms. On an unknown date, the outcome of the injection site pain, fever and influenza-like symptoms were unknown.   It was unknown if the reporter considered the injection site pain, fever and influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The patient had severe pain at the injection site, fever and flu like symptoms. The patient was young for her age. Additional details were provided as follows: The patient had severe pain at the injection site, fever and flu like symptoms. The patient was young for her age.  The patient noted that she pretty much had all of the ones  adverse event listed in the labelling.
was just tired; a little bit of headache, nothing too crazy; Sore throat; Diarrhea; Sore throat hurt and making me cough a lot; This is a spontaneous report received from a contactable consumer (patient). A 59-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EP7534, Expiry date: unknown) via an unspecified route of administration in the left upper arm on 20Mar2021 as a single dose for covid-19 immunization. Medical history included none. The patient's concomitant medications were not reported. On 21Mar2021, night after first dose of the covid shot patient was just tired, experienced a little bit of headache, nothing too crazy, not quite herself, she could function most out of the day, today she woke up and she a little bit sore throat and she was having with fluid. She was more concerned about the first dose as her sore throat hurt, making her cough a lot. Patient also had diarrhea a couple of times. So patient was not sure that she should be concerned or normal. She would like to know if this was like normal side effects. The second dose of bnt162b2 was due on 10April 2021. Therapeutic measures taken as a result of the events included treatment with Tylenol 500 mg like 2 hours ago, she took one Tylenol today for tiredness, a little bit of headache and sort throat. The clinical outcome of all events was unknown.  No follow-up attempts are possible. No further information is expected.
5/21/04: throat felt swollen in evening. 5/22/04: no fever, but throat sore, noticed swollen gland under right ear: fatigue. 5/24/04 visit with PCP: seen by CNP: adenopathy assessed.
vomiting; upset stomach; This spontaneous report as received from a medical assistant refers to a 65-year-old male patient with hypertension, bipolar disorder, benign prostatic hyperplasia (BPH), chronic idiopathic constipation, chronic pain, dyslipidemia, erectile dysfunction (ED), anxiety disorder, insomnia, lumbar displacement/herniation, lumbar sacral neuritis, "nevesis" back, panic disorder and pre-diabetes. The patient had an drug/allergic reaction to buspirone hydrochloride (BUSPAR), clonazepam (KLONOPIN), hydromorphone hydrochloride (DILAUDID), acetaminophen (+) codeine phosphate (TYLENOL WITH CODEINE) and escitalopram oxalate.  Concomitant therapies included lisinopril, clonidine, diclofenac sodium, alprazolam, zaleplon, zolpidem, ibuprofen 800mg, pregabalin (LYRICA), aspirin, pantoprazole and ondansetron.   On 22-JUL-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 1 dose, intramuscularly, lot # S002582, expiration date 10-AUG-2020 (anatomical location was not provided), as the patient was due for the vaccine.  On 23-JUL-2019 at midnight, the patient began vomiting, which continued through 23-JUL-2019.  On 24-JUL-2019, the patient recovered from vomiting but was still reporting an "upset stomach".  The patient sought medical attention and called a physician. No treatment was given for the adverse events.  At the time of the report the outcome of "upset stomach" was not recovered. The relatedness between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not provided.
Patient had a Vasovagal reaction to the vaccine 5 minutes after dose. She completely fainted, possibly hitting her head on the floor, then regained consciousness shortly thereafter. Paramedics were called to evaluate her but she was not taken to the ER.
felt terrible / still feel bad; red spot is the size of a woman's hand; This case was reported by a consumer via interactive digital media and described the occurrence of feels awful in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd July 2020, the patient received Shingrix. On 23rd July 2020, 1 days after receiving Shingrix, the patient experienced feels awful and injection site erythema. On an unknown date, the outcome of the feels awful and injection site erythema were not recovered/not resolved.   It was unknown if the reporter considered the feels awful and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient herself. The age at vaccination was not reported. The patient received Shingrix vaccine 2 days ago and felt terrible. The patient experienced redness around shot size of a woman's hand. The case has been linked with case US2020AMR143189 reported as same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR143189:same reporter
Swelling on his face; Rash on his face; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swelling on his face) and RASH (Rash on his face) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced SWELLING FACE (Swelling on his face) and RASH (Rash on his face). At the time of the report, SWELLING FACE (Swelling on his face) and RASH (Rash on his face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided.
(R) thigh had some itching & swelling some erythema that seems to be spreading from under the band aid that still remains. Child had a fever day after vaccine given, no fever today. put on cephalexin told to return 5/9/19 for recheck.
At time of injection I experienced immediate pain similar to hitting bone or nerve. I am unable to raise or rotate arm without severe pain. Also, I am unable to sleep on my right side.
Pt presented to the dermatologist with atypical varicella subsequent to vaccination with varicella virus vaccine live.
29 yo m with syncopal episode post vaccination with immediate recovery. EMS offered and declined.
Lightheaded - 10 minutes after, Headache - 20 minutes after, General Malaise - 1 hour after; 21 hours after nausea, painful muscle aches, chills, fever of 101.2; this cycle repeated three times when the Tylenol wore off. Incredible soreness and moderate swelling at the injection site - 6 hours post-vaccine
There are 5 blood clots in total; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (There are 5 blood clots in total) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026021A and 020B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (There are 5 blood clots in total) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (There are 5 blood clots in total) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.    This case was linked to MOD-2021-356470 (Patient Link).; Sender's Comments: This case concerns a 53-year-old, female patient with no previous relevant medical history reported, who experienced the unexpected event of thrombosis. The events occurred on an unknown number of days after the second dose of mRNA-1273. The rechallenge was not applicable since the events happened after the second dose. The benefit-risk relationship of mRNA-1273 is not affected by this report. further information was requested.
Injection site pain and swelling within 2 hours Fever of approximately 101 degrees within 12 hours, lasting 24 hours Severe body aches, beginning 10-12 hours after shot, lasting 24 hours Intermittent sharp, shooting pain in various joints and muscles, lasting about 36 hours Dizziness, mental confusion, fatigue, beginning within 12 hours, lasting 24-36 hours
Pt recvd 1st dose of Hep B vax 5MAR91 & on 29MAR91 pt devel hypersensitivity synd;
On 2/18/21, 10 days after receiving the vaccine, I donated blood as usual.  About 30 minutes later I was light headed, had abdominal cramping pain, bowel emptying and possibly fainted.  I was transported by EMTs to the ER and was later diagnosed with inflamitory bowel by a CT scan.  I took antibiotics and was feeling fine.  My gastroenterologist performed a colonoscopy on 3/24/21 and the findings were that I was healed and tissue samples were normal.  3/25/21 I had an annual physical and was told I was in good health.  Later that afternoon I began feeling light headed upon standing.  In the night I called my health insurance hotline because my blood oxygen meter was beeping  continuously.  The Dr. on call told me to go by ambulance to the ER.  When sitting or lying down, I felt fine and all the tests at the ER for my heart and my vital signs were good.  A few hours later, they did a hest Xray and then a CT scan of my lungs which showed a saddle embulism.  I had also  thought I had bruised my knee if and when I fainted on 2/18 and  1o hours later a blood lot was found by ultrasound of my left knee.  I was given blood thinners in the ER and then in ICU where I spent the next night.  I am now taking Eleris.  I was also given pantoprozole for GERD coughing the next day.  I continue to have periods of abdominal ramping/pain, light headedness in waves and pressure in my head.  I have disontinued the stomach medication with some feeling better with the lightheadedness.
This spontaneous report was received from a medical assistant concerning an unknown number of patients of an unknown gender and age. Co-suspect and concomitant therapies were not reported. On an unknown date, the patients were vaccinated with a dose of GARDASIL (dose, dose number and route were not reported) lot number K004204, expiration date 12-JAN-2017, expiration. Co-suspect and concomitant therapies were not reported. The medical assistant reported seven (7) doses of GARDASIL that were exposed to temperatures as low as 33 F since 18-AUG-2014, were administered to unspecified patients on unspecified dates. This temperature excursion was not supported. No adverse experience has been reported. Additional information has been requested.
01/03/23 presents to ED for "breathing problem". PMHx of "HTN, CAD, CHF, recent hip fracture sp repair"
Discharge Provider : MD Primary Care Provider:  MD Admission Date: 9/4/2022 Discharge Date: Sep 13, 2022  PRESENTING PROBLEM: Severe sepsis Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus Community acquired pneumonia of right lower lobe of lung COVID-19 Bacteremia   HOSPITAL COURSE: 34 year old female w/PMH including T2DM, severe persistent asthma with no baseline oxygen needs, OSA, obesity, presenting with worsening dyspnea, fatigue, general malaise, and right-sided chest wall pain. Initial workup revealed acute hypoxemic respiratory failure secondary to COVID-19 pneumonia, superimposed bacterial PNA, and DKA. She was started on IV insulin, given steroids in the ED, and admitted to the ICU for further management.  While in the ICU, her oxygen requirements improved but she was found to have MRSA bacteremia. Vancomycin was started and ID were consulted.    Once the patient was taken off of EndoTool and switched to basal bolus insulin she was transferred to the medical floor.  Sputum culture was positive for MRSA and therefore she was being treated for pneumonia secondary to MRSA.  Infectious Disease gave final recommendation with continuous vancomycin infusion for a total of 4 weeks.  Home oxygen eval showed that the patient needs 2 liters of nasal cannula continuous which was arranged for her.  PICC line was placed prior to discharge.   Of note few days prior to discharge, the patient glucose level was dropping the for her and Lantus was decreased as well as her pre meal insulin.  Endocrinology was following and adjusted her bolus insulin and provided recommendations on discharge.    The patient was discharged home in a stable condition with home health care and discharge instructions provided.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI (NSTEMI), TYPE 1 MI
pt recvd 1st dose of Hep B vax 21JUL92 & on 29AUG92 pt devel h/a, abd pain, dark red spots on extremities, & swelling of ankles; pt was hospitalized & PE revealed gross blood in the stool; dx of schoenlein Henoch synd was made;
Received flu vaccine at 2:35PM. History of prior flu vaccines with no adverse reaction.  Received covid vaccine at 2:45 PM (via Pharmacy covid clinic on site) - They will complete VAERS report for the COVID (Moderna) vaccine. 11 minutes after Moderna vaccine she began to feel "weird" Nurse arrived on scene 2 minutes later. She had hives on neck, chest, and shoulders. LCTA and no difficulty swallowing. Benadry PO 25mg x 2 tablets given at 3:05 PM Symptoms of palpitations, heavy chest, incoordination, and dizziness progressed 3:45 PM police arrive 3:57 PM EMS arrive 4:07 depart to hospital (10/30/23) Patient is currently in Hospital (as of 11/1/23 10:45 AM)
patient menses started earlier than normal. she is now having light bleeding that lasts for one week and occurs every other week